skinny.

Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives

Expanding GLP-1 Usage Into Type 1 Diabetes With Viral Shah, MD

Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode of Diabetes Dialogue, recorded on-site at the American Association of Clinical Endocrinology (AACE) Annual Meeting 2026 in Las Vegas, Nevada, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, welcome Viral Shah, MD, professor of endocrinology at Indiana University, for a discussion centered on the evolving role of GLP-1 receptor agonists and broader diabetes classification in type 1 diabetes care. Shah challenges the traditional distinction between type 1 and type 2 diabetes…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.